Status unknownNCT03420573Updated Feb 5, 2018

Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection

An observational study in Parkinson Disease, sponsored by Kasr El Aini Hospital. Status unknown. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2018-02-05.

Sponsored by Kasr El Aini Hospital · Observational

The sponsor has not verified this record recently (last verified Jan 2018), so the status shown — last known as Not yet recruiting — may be out of date.

Study type: Observational
Model: Cohort
Time perspective: Prospective
Enrollment: 300
Ages: 50 Years to 80 Years
Sex: All

Study summary

There is association between Hepatitis C and Parkinson's Disease as shown from previous studies. The clinical profile and natural history is not fully studied yet. We aim at studying the clinical characteristics of Parkinson's Disease in patients with hepatitis C infection.

Conditions studied

Parkinson Disease

Browse trials for

Who can participate

Ages eligible: 50 Years to 80 Years
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Parkinson's Disease patients with hepatitis C infection

Inclusion criteria

Patient with history of Parkinson's Disease and Hepatitis C infection.

Exclusion criteria

Exclusion Criteria:

Advanced liver cirrhosis.
Patients with hepatic failure.
Symptoms of Parkinson's plus syndrome.

Study design

Observational model: Cohort
Time perspective: Prospective
Enrollment: 300 participants (estimated)
Target follow-up: 1 Year
Patient registry: Yes

What researchers measure

Primary outcomes

Score of UPDRS
Severity of Motor and non motor symptoms
Time frame: 2 years

Study locations

No study locations are listed for this record.

References and documents

Publications

Pakpoor J, Noyce A, Goldacre R, Selkihova M, Mullin S, Schrag A, Lees A, Goldacre M. Viral hepatitis and Parkinson disease: A national record-linkage study. Neurology. 2017 Apr 25;88(17):1630-1633. doi: 10.1212/WNL.0000000000003848. Epub 2017 Mar 29. PubMed 28356465 ↗
Kim JM, Jang ES, Ok K, Oh ES, Kim KJ, Jeon B, Jo HJ, Ki M, Jeong SH. Association between hepatitis C virus infection and Parkinson's disease. Mov Disord. 2016 Oct;31(10):1584-1585. doi: 10.1002/mds.26755. No abstract available. PubMed 27549922 ↗
Golabi P, Otgonsuren M, Sayiner M, Arsalla A, Gogoll T, Younossi ZM. The Prevalence of Parkinson Disease Among Patients With Hepatitis C Infection. Ann Hepatol. 2017 May-Jun;16(3):342-348. doi: 10.5604/16652681.1235476. PubMed 28425403 ↗

Individual participant data

Plan to share: Undecided — Anonymous Demographic data ,severity of symptoms, score results

Registry details

Key details

Study ID: NCT03420573
Lead sponsor: Kasr El Aini Hospital
Responsible party: Shaimaa El-Jaafary (Lecturer of Neurology, Kasr El Aini Hospital) — Principal investigator
First posted: Feb 5, 2018
Start date: Mar 2018 (estimated)
Primary completion: Oct 2019 (estimated)
Completion: Mar 2020 (estimated)
Last update: Feb 5, 2018

Study contacts

Shaimaa I. El-Jaafary, MD

Contact

shaimaa_jafary@kasralainy.edu.eg

+2 01119213915

Hanan A. Amer, MD

Contact

hanan.amer@kasralainy.edu.eg

Shaimaa I. El-Jaafary, MD

study director · Director of Kasr Alainy Movement Disorders Unit KAMDU

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hepatitis C→

Other studies from this sponsor

Kasr El Aini Hospital

Start the discussion